| College | Liberal Arts and Sciences |
|---|---|
| Head | Mr Alan Porter |
Blaug, R. 1986. John Rawls and the protection of liberty. Social Theory and Practice. 12 (2), pp. 241-258.
Clow, A., Glover, V. and Sandler, M. 1985. Triazolam, an anomalous benzodiazepine receptor ligand: in vitro characterization of alprazolam and triazolam binding. Journal of Neurochemistry. 45 (2), pp. 621-625. https://doi.org/10.1111/j.1471-4159.1985.tb04031.x
Murugaiah, K., Theodorou, A., Clow, A., Jenner, P. and Marsden, C.D. 1985. Effects of discontinuous drug administration on the development of dopamine receptor supersensitivity during chronic trifluoperazine or cis-flupenthixol administration to rats. Psychopharmacology. 86 (1-2), pp. 228-232. https://doi.org/10.1007/BF00431715
Clow, A., Glover, V., Armando, I. and Sandler, M. 1983. New endogenous benzodiazepine receptor ligand in human urine: identity with endogenous monoamine oxidase inhibitor? Life Sciences. 33 (8), pp. 735-741. https://doi.org/10.1016/0024-3205(83)90778-6
Clow, A., Stolerman, I.P., Murray, R.M. and Sandler, M. 1983. Ethanol preference in rats: increased consumption after intraventricular administration of tetrahydropapaveroline. Neuropharmacology. 22 (4), pp. 563-565. https://doi.org/10.1016/0028-3908(83)90181-8
Bhattacharya, S.K., Glover, V., Sandler, M., Clow, A., Topham, A., Bernadt, M. and Murray, R.M. 1982. Raised endogenous monoamine oxidase inhibitor output in postwithdrawal alcoholics: effects of L-dopa and ethanol. Biological Psychiatry. 17 (7).
Murugaiah, K., Theodorou, A., Mann, S., Clow, A., Jenner, P. and Marsden, C.D. 1982. Chronic continuous administration of neuroleptic drugs alters cerebral dopamine receptors and increases spontaneous dopaminergic action in the striatum. Nature. 296, pp. 570-572. https://doi.org/10.1038/296570a0
Kolbe, H., Clow, A., Jenner, P. and Marsden, C.D. 1981. Neuroleptic-induced acute dystonic reactions may be due to enhanced dopamine release on to supersensitive postsynaptic receptors. Neurology. 31 (4(2)), pp. 434-439.
Dyer, R.G., Murugaiah, K., Theodorou, A., Clow, A., Jenner, P. and Marsden, C.D. 1981. During one year's neuroleptic treatment in rats, striatal dopamine receptor blockade decreases but serum prolactin levels remain elevated. Life Sciences. 28 (2), pp. 167-174. https://doi.org/10.1016/0024-3205(81)90549-X
Theodorou, A., Gommeren, W., Clow, A., Leysen, J., Jenner, P. and Marsden, C.D. 1981. Chronic neuroleptic treatment specifically alters the number of dopamine receptors in rat brain. Life Sciences. 28 (14), pp. 1621-1627. https://doi.org/10.1016/0024-3205(81)90317-9
Jenner, P., Clow, A., Reavill, C., Theodorou, A. and Marsden, C.D. 1980. Stereoselective actions of substituted benzamide drugs on cerebral dopamine mechanisms. Journal of Pharmacy and Pharmacology. 32 (1), pp. 39-44. https://doi.org/10.1111/j.2042-7158.1980.tb12842.x
Clow, A., Jenner, P., Theodorou, A. and Marsden, C.D. 1980. A comparison of striatal and mesolimbic dopamine function in the rat during 6-month trifluoperazine administration. Psychopharmacology. 69 (3), pp. 227-233. https://doi.org/10.1007/BF00433087
Clow, A., Theodorou, A., Jenner, P. and Marsden, C.D. 1980. Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic administration. European Journal of Pharmacology. 63 (2-3), pp. 135-144. https://doi.org/10.1016/0014-2999(80)90437-9
Clow, A., Theodorou, A., Jenner, P. and Marsden, C.D. 1980. Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration. European Journal of Pharmacology. 63 (2-3), pp. 145-157. https://doi.org/10.1016/0014-2999(80)90438-0
Luscombe, G., Clow, A., Jenner, P. and Marsden, C.D. 1979. Antagonism by propanol of central dopamine receptor stimulation is not related to β-adrenergic blockade. Journal of Pharmacy and Pharmacology. 31 (1), pp. 355-356. https://doi.org/10.1111/j.2042-7158.1979.tb13522.x
Clow, A., Jenner, P., Theodorou, A. and Marsden, C.D. 1979. Neuroleptic drugs and the dopamine hypothesis. Lancet. 313 (8122), p. 934. https://doi.org/10.1016/S0140-6736(79)91424-7
Clow, A., Jenner, P., Theodorou, A. and Marsden, C.D. 1979. Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six months. Nature. 278, pp. 59-61. https://doi.org/10.1038/278059a0
Clow, A., Jenner, P. and Marsden, C.D. 1979. Changes in dopamine-mediated behaviour during one year's neuroleptic administration. European Journal of Pharmacology. 57 (4), pp. 365-375. https://doi.org/10.1016/0014-2999(79)90499-0
Jenner, P., Elliott, P.N.C., Clow, A., Reavill, C. and Marsden, C.D. 1978. A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs. Journal of Pharmacy and Pharmacology. 30 (1), pp. 46-48. https://doi.org/10.1111/j.2042-7158.1978.tb13151.x
Clow, A., Jenner, P., Theodorou, A. and Marsden, C.D. 1978. An experimental model of tardive dyskinesias. Life Sciences. 23 (5), pp. 421-423. https://doi.org/10.1016/0024-3205(78)90146-7
Jenner, P., Clow, A., Reavill, C., Theodorou, A. and Marsden, C.D. 1978. A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugs. Life Sciences. 23 (6), pp. 557-561. https://doi.org/10.1016/0024-3205(78)90032-2